Processes for the preparation and purification of gabapentin enacarbil
AssigneeTeva Pharmaceutical Industries Ltd.
InventorsElena Ben Moha-Lerman, Tamar Nidam, Meital Cohen, Sharon Avhar-Maydan, Anna Balanov
Life of this patent
Estimating the term…
Abstract
Gabapentin enacarbil was prepared and purified from intermediates such as 1-haloalkyl carbamate or carbonate and diacid acetal skeleton. For example, a 1-haloalkyl carbonate or carbamate was prepared by combining a C1 to C10 alcohol or C1 to C10 primary amine, a solvent selected from the group consisting of: acetonitrile, C3 to C7 ketone, C5 to C10 ether, C2 to C7 ester, C5 to C10 hydrocarbon and a combination thereof; a 1-haloalkyl haloformate of the following formula: wherein each X is independently selected from Br, I, or Cl; R1 is alkyl or H; and a C6 to C21 tertiary amine.
Claims20
A process for purifying gabapentin enacarbil (GBPE) from a mixture with nitrophenol (NP) and/or NP derivatives comprising reducing the NP and NP derivatives in the mixture, followed by acidic extraction.
A process for purifying gabapentin enacarbil, comprising:
- loading a mixture containing gabapentin enacarbil, nitrophenol, and/or nitrophenol derivatives on a column filled with cross-linked dextran gel in toluene;
- and eluting purified gabapentin enacarbil with toluene or a toluene/hexane solution.
Dependencies are inferred from the claim text.